Literature DB >> 9059341

Clinical significance of the determination of angiogenic factors.

M Toi1, T Taniguchi, Y Yamamoto, T Kurisaki, H Suzuki, T Tominaga.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 9059341     DOI： 10.1016/s0959-8049(96)00397-8

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  11 in total

Review 1.  VEGF as a mediator of tumor-associated immunodeficiency.

Authors:  J E Ohm; D P Carbone
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 2.  Natural selection of tumor variants in the generation of "tumor escape" phenotypes.

Authors:  Hung T Khong; Nicholas P Restifo
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

3.  Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesis associated with elevated levels of VEGF.

Authors:  Yuhui Huang; Xiaolan Chen; Mikhail M Dikov; Sergey V Novitskiy; Claudio A Mosse; Li Yang; David P Carbone
Journal:  Blood       Date:  2007-03-21       Impact factor: 22.113

4.  Correlation between basic fibroblast growth factor immunostaining of stromal cells and stromelysin-3 mRNA expression in human breast carcinoma.

Authors:  C Linder; P Byström; G Engel; G Auer; U Aspenblad; H Strander; S Linder
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

5.  Evaluation and Comparison of Vascular Endothelial Growth Factor Expression between Ameloblastoma and Keratocystic Odontogenic Tumor.

Authors:  Thayalan Dineshkumar; Nataraj Priyadharsini; U Punitha Gnanaselvi; Srinivasan Sathishkumar; R P Srikanth; A E Nagarathinam
Journal:  J Int Oral Health       Date:  2015-01

6.  Inhibition of vascular endothelial growth factor by small interfering RNA upregulates differentiation, maturation and function of dendritic cells.

Authors:  Haiyan Wang; Luping Zhang; Shaoyan Zhang; Yannian Li
Journal:  Exp Ther Med       Date:  2014-11-11       Impact factor: 2.447

7.  Significance of membrane type 1 matrix metalloproteinase expression in breast cancer.

Authors:  S Ishigaki; M Toi; T Ueno; H Matsumoto; M Muta; M Koike; M Seiki
Journal:  Jpn J Cancer Res       Date:  1999-05

8.  Hypoxia promotes tumor growth in linking angiogenesis to immune escape.

Authors:  Salem Chouaib; Yosra Messai; Sophie Couve; Bernard Escudier; Meriem Hasmim; Muhammad Zaeem Noman
Journal:  Front Immunol       Date:  2012-02-23       Impact factor: 7.561

9.  Expression of basic fibroblast growth factor is associated with poor outcome in non-Hodgkin's lymphoma.

Authors:  I Pazgal; Y Zimra; C Tzabar; E Okon; E Rabizadeh; M Shaklai; O Bairey
Journal:  Br J Cancer       Date:  2002-06-05       Impact factor: 7.640

10.  Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n=905).

Authors:  J P Dales; S Garcia; S Carpentier; L Andrac; O Ramuz; M N Lavaut; C Allasia; P Bonnier; C Taranger-Charpin
Journal:  Br J Cancer       Date:  2004-03-22       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.